| Betulinic acid derivatives as anticancer agents: structure activity relationship R Mukherjee, V Kumar, SK Srivastava, SK Agarwal, AC Burman Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2006 | 186 | 2006 |
| Emerging targets for diabetes RK Vats, V Kumar, A Kothari, A Mital, U Ramachandran Current science, 241-249, 2005 | 112 | 2005 |
| 1, 8‐Naphthyridine derivatives: A review of multiple biological activities A Madaan, R Verma, V Kumar, AT Singh, SK Jain, M Jaggi Archiv der Pharmazie 348 (12), 837-860, 2015 | 111 | 2015 |
| Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid … V Kumar, A Bonifazi, MP Ellenberger, TM Keck, E Pommier, R Rais, ... Journal of medicinal chemistry 59 (16), 7634-7650, 2016 | 94 | 2016 |
| Synthesis and cytotoxic activity of heterocyclic ring-substituted betulinic acid derivatives V Kumar, N Rani, P Aggarwal, VK Sanna, AT Singh, M Jaggi, N Joshi, ... Bioorganic & medicinal chemistry letters 18 (18), 5058-5062, 2008 | 87 | 2008 |
| 1, 8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity V Kumar, M Jaggi, AT Singh, A Madaan, V Sanna, P Singh, PK Sharma, ... European journal of medicinal chemistry 44 (8), 3356-3362, 2009 | 57 | 2009 |
| Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D3 Receptor NAH Kumar V, Moritz AE, Keck TM, Bonifazi A, Ellenberger MP, Sibley CD, Free ... Journal of Medicinal Chemistry 60 (2), 580-593, 2017 | 55 | 2017 |
| Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 … AHN Vivek Kumar, Amy E. Moritz, Thomas M. Keck, Alessandro Bonifazi, Michael ... Journal of Medicinal Chemistry 60 (4), 1478-1494, 2017 | 49 | 2017 |
| Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism NAH Bonifazi A, Yano H, Ellenberger MP, Muller L, Kumar V, Zou MF, Cai NS ... J. Med. Chem. 60 (7), 2890-28907, 2017 | 43 | 2017 |
| Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor … MF Zou, TM Keck, V Kumar, P Donthamsetti, M Michino, C Burzynski, ... Journal of medicinal chemistry 59 (7), 2973-2988, 2016 | 39 | 2016 |
| Nanopharmacological force sensing to reveal allosteric coupling in transporter binding sites R Zhu, D Sinwel, PS Hasenhuetl, K Saha, V Kumar, P Zhang, C Rankl, ... Angewandte Chemie 128 (5), 1751-1754, 2016 | 32 | 2016 |
| Investigation of the binding and functional properties of extended length D3 dopamine receptor-selective antagonists CA Furman, RA Roof, AE Moritz, BN Miller, TB Doyle, RB Free, AK Banala, ... European Neuropsychopharmacology 25 (9), 1448-1461, 2015 | 28 | 2015 |
| Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen MGP Sangeeta Ray Banerejee, Vivek Kumar, Ala Lisok, Donika Plyku, Zora ... The Journal of Nuclear Medicine, 2018 | 26* | 2018 |
| Anti-inflammatory activity of a naphthyridine derivative (7-chloro-6-fluoro-N-(2-hydroxy-3-oxo-1-phenyl-3-(phenylamino) propyl)-4-oxo-1-(prop-2-yn-1-yl)-1, 4-dihydro-1, 8 … A Madaan, V Kumar, R Verma, AT Singh, SK Jain, M Jaggi International Immunopharmacology 15 (3), 606-613, 2013 | 20 | 2013 |
| Synthesis of quinazolines as tyrosine kinase inhibitors SK Srivastava, V Kumar, SK Agarwal, R Mukherjee, AC Burman Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2009 | 20 | 2009 |
| Novel and High Affinity Fluorescent Ligands for the Serotonin Transporter Based on (S)-Citalopram V Kumar, T Rahbek-Clemmensen, CB Billesbølle, TN Jorgensen, ... ACS medicinal chemistry letters 5 (6), 696-699, 2014 | 19 | 2014 |
| Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents V Kumar, MM Mudgal, N Rani, A Jha, M Jaggi, AT Singh, VK Sanna, ... Journal of Enzyme Inhibition and Medicinal Chemistry 24 (3), 763-770, 2009 | 18 | 2009 |
| The Multifaceted Reactivity of o-Fluoranil V Kumar, S Ramanathan, D Sang, X Chen, DM Lemal The Journal of Organic Chemistry 77 (2), 966-970, 2012 | 17 | 2012 |
| Chiral resolution and serendipitous fluorination reaction for the selective dopamine D3 receptor antagonist BAK2-66 V Kumar, AK Banala, EG Garcia, J Cao, TM Keck, A Bonifazi, ... ACS Medicinal Chemistry Letters 5 (6), 647-651, 2014 | 15 | 2014 |
| Anticancer and immunomodulatory activities of novel 1, 8-naphthyridine derivatives V Kumar, A Madaan, VK Sanna, M Vishnoi, N Joshi, AT Singh, M Jaggi, ... Journal of Enzyme Inhibition and Medicinal Chemistry 24 (5), 1169-1178, 2009 | 13 | 2009 |
Newman Amy HauckNational Institue on Drug Abuse-Intramural Research Program, NIH在 intra.nida.nih.gov 的电子邮件经过验证
